These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38462218)

  • 1. Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial.
    Piloquet H; Vrignaud B; Gillaizeau F; Capronnier O; Berding K; Günther J; Hecht C; Regimbart C;
    Am J Clin Nutr; 2024 May; 119(5):1259-1269. PubMed ID: 38462218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants.
    Lagkouvardos I; Intze E; Schaubeck M; Rooney JP; Hecht C; Piloquet H; Clavel T
    Am J Clin Nutr; 2023 Feb; 117(2):326-339. PubMed ID: 36811568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants.
    Maldonado J; Cañabate F; Sempere L; Vela F; Sánchez AR; Narbona E; López-Huertas E; Geerlings A; Valero AD; Olivares M; Lara-Villoslada F
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):55-61. PubMed ID: 21873895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.
    Estorninos E; Lawenko RB; Palestroque E; Sprenger N; Benyacoub J; Kortman GAM; Boekhorst J; Bettler J; Cercamondi CI; Berger B
    Am J Clin Nutr; 2022 Jan; 115(1):142-153. PubMed ID: 34617558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of infant formula supplemented with prebiotics compared with synbiotics on growth up to the age of 12 mo: a randomized controlled trial.
    Szajewska H; Ruszczyński M; Szymański H; Sadowska-Krawczenko I; Piwowarczyk A; Rasmussen PB; Kristensen MB; West CE; Hernell O
    Pediatr Res; 2017 May; 81(5):752-758. PubMed ID: 28060791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study.
    Phavichitr N; Wang S; Chomto S; Tantibhaedhyangkul R; Kakourou A; Intarakhao S; Jongpiputvanich S; ; Roeselers G; Knol J
    Sci Rep; 2021 Feb; 11(1):3534. PubMed ID: 33574421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial.
    Maldonado-Lobón JA; Gil-Campos M; Maldonado J; López-Huertas E; Flores-Rojas K; Valero AD; Rodríguez-Benítez MV; Bañuelos O; Lara-Villoslada F; Fonollá J; Olivares M
    Pharmacol Res; 2015; 95-96():12-9. PubMed ID: 25697549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a whey-predominant starter formula containing LCPUFAs and oligosaccharides (FOS/GOS) on gastrointestinal comfort in infants.
    Vivatvakin B; Mahayosnond A; Theamboonlers A; Steenhout PG; Conus NJ
    Asia Pac J Clin Nutr; 2010; 19(4):473-80. PubMed ID: 21147707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial.
    Goehring KC; Marriage BJ; Oliver JS; Wilder JA; Barrett EG; Buck RH
    J Nutr; 2016 Dec; 146(12):2559-2566. PubMed ID: 27798337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial.
    Maldonado J; Gil-Campos M; Maldonado-Lobón JA; Benavides MR; Flores-Rojas K; Jaldo R; Jiménez Del Barco I; Bolívar V; Valero AD; Prados E; Peñalver I; Olivares M
    BMC Pediatr; 2019 Oct; 19(1):361. PubMed ID: 31630683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: randomized multicenter trial.
    Giovannini M; Verduci E; Gregori D; Ballali S; Soldi S; Ghisleni D; Riva E;
    J Am Coll Nutr; 2014; 33(5):385-93. PubMed ID: 25302927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial.
    Gil-Campos M; López MÁ; Rodriguez-Benítez MV; Romero J; Roncero I; Linares MD; Maldonado J; López-Huertas E; Berwind R; Ritzenthaler KL; Navas V; Sierra C; Sempere L; Geerlings A; Maldonado-Lobón JA; Valero AD; Lara-Villoslada F; Olivares M
    Pharmacol Res; 2012 Feb; 65(2):231-8. PubMed ID: 22155106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
    Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.
    Alliet P; Vandenplas Y; Roggero P; Jespers SNJ; Peeters S; Stalens JP; Kortman GAM; Amico M; Berger B; Sprenger N; Cercamondi CI; Corsello G
    Nutr J; 2022 Feb; 21(1):11. PubMed ID: 35193609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial.
    Closa-Monasterolo R; Gispert-Llaurado M; Luque V; Ferre N; Rubio-Torrents C; Zaragoza-Jordana M; Escribano J
    Clin Nutr; 2013 Dec; 32(6):918-27. PubMed ID: 23498848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of infectious diseases in infants fed follow-on formula containing synbiotics: an observational study.
    Picaud JC; Chapalain V; Paineau D; Zourabichvili O; Bornet FR; Duhamel JF
    Acta Paediatr; 2010 Nov; 99(11):1695-700. PubMed ID: 20560895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial.
    Nowacki J; Lee HC; Lien R; Cheng SW; Li ST; Yao M; Northington R; Jan I; Mutungi G
    Nutr J; 2014 Nov; 13():105. PubMed ID: 25373935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the gut-lung axis by synbiotic feeding to infants in a randomized controlled trial.
    Sjödin KS; Sjödin A; Ruszczyński M; Kristensen MB; Hernell O; Szajewska H; West CE
    BMC Biol; 2023 Feb; 21(1):38. PubMed ID: 36803508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants.
    Béghin L; Tims S; Roelofs M; Rougé C; Oozeer R; Rakza T; Chirico G; Roeselers G; Knol J; Rozé JC; Turck D
    Clin Nutr; 2021 Mar; 40(3):778-787. PubMed ID: 32893049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stool microbiome, pH and short/branched chain fatty acids in infants receiving extensively hydrolyzed formula, amino acid formula, or human milk through two months of age.
    Kok CR; Brabec B; Chichlowski M; Harris CL; Moore N; Wampler JL; Vanderhoof J; Rose D; Hutkins R
    BMC Microbiol; 2020 Nov; 20(1):337. PubMed ID: 33167908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.